Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 245


Definitive Chemoradiotherapy for Esophageal Squamous Cell Cancer: A Matter of Standard.

Adenis A, Crehange G, Conroy T.

J Clin Oncol. 2019 Sep 10;37(26):2379. doi: 10.1200/JCO.19.00963. Epub 2019 Jul 29. No abstract available.


Efficacy and Safety of Two Neoadjuvant Strategies With Bevacizumab in MRI-Defined Locally Advanced T3 Resectable Rectal Cancer: Final Results of a Randomized, Noncomparative Phase 2 INOVA Study.

Borg C, Mantion G, Boudghène F, Mornex F, Ghiringhelli F, Adenis A, Azria D, Balosso J, Ben Abdelghani M, Bachet JB, Vendrely V, François Y, Conroy T, Rio E, Roullet B, Spaëth D, Quero L, Lakkis Z, Coudert M, Ionescu-Goga M, Tanang A, André T.

Clin Colorectal Cancer. 2019 Sep;18(3):200-208.e1. doi: 10.1016/j.clcc.2019.04.006. Epub 2019 May 3.


The Fight against HIV-Associated Disseminated Histoplasmosis in the Americas: Unfolding the Different Stories of Four Centers.

Nacher M, Leitao TS, Gómez BL, Couppié P, Adenis A, Damasceno L, Demar M, Samayoa B, Cáceres DH, Pradinaud R, Sousa AQ, Arathoon E, Restrepo A.

J Fungi (Basel). 2019 Jun 17;5(2). pii: E51. doi: 10.3390/jof5020051.


Quantitative evaluation of liver metastases density on computed tomography: A new tool to evaluate early response to bevacizumab-containing chemotherapy.

Mazard T, Assenat E, Dupuy M, Mollevi C, René A, Adenis A, Chauffert B, Boucher E, Francois E, Pierga JY, Ducreux M, Ychou M, Gallix B.

Dig Liver Dis. 2019 Aug;51(8):1185-1191. doi: 10.1016/j.dld.2019.03.028. Epub 2019 May 10.


High prevalence of hepatitis B and syphilis in illegal gold miners in French Guiana.

Douine M, Schaub R, Jardin H, Adenis A, Nacher M, Hureau-Mutricy L, Vreden S, Mosnier E, Pisoni A, Tuaillon E.

Clin Microbiol Infect. 2019 Aug;25(8):1051-1053. doi: 10.1016/j.cmi.2019.04.023. Epub 2019 Apr 26. No abstract available.


Incidence and trends in immune reconstitution inflammatory syndrome associated with Histoplasma capsulatum among people living with HIV: a 20-year case series and literature review.

Melzani A, De Reynal De Saint Michel R, Ntab B, Djossou F, Epelboin L, Nacher M, Blanchet D, Demar M, Couppie P, Adenis A.

Clin Infect Dis. 2019 Mar 28. pii: ciz247. doi: 10.1093/cid/ciz247. [Epub ahead of print]


Quantifying circulating cell-free DNA in humans.

Meddeb R, Dache ZAA, Thezenas S, Otandault A, Tanos R, Pastor B, Sanchez C, Azzi J, Tousch G, Azan S, Mollevi C, Adenis A, El Messaoudi S, Blache P, Thierry AR.

Sci Rep. 2019 Mar 26;9(1):5220. doi: 10.1038/s41598-019-41593-4.


The 4th St. Gallen EORTC Gastrointestinal Cancer Conference: Controversial issues in the multimodal primary treatment of gastric, junctional and oesophageal adenocarcinoma.

Lutz MP, Zalcberg JR, Ducreux M, Adenis A, Allum W, Aust D, Carneiro F, Grabsch HI, Laurent-Puig P, Lordick F, Möhler M, Mönig S, Obermannova R, Piessen G, Riddell A, Röcken C, Roviello F, Schneider PM, Seewald S, Smyth E, van Cutsem E, Verheij M, Wagner AD, Otto F.

Eur J Cancer. 2019 May;112:1-8. doi: 10.1016/j.ejca.2019.01.106. Epub 2019 Mar 15. Review.


Continuation versus discontinuation of first-line chemotherapy in patients with metastatic squamous cell oesophageal cancer: A randomised phase II trial (E-DIS).

Adenis A, Bennouna J, Etienne PL, Bogart E, Francois E, Galais MP, Ben Abdelghani M, Michel P, Metges JP, Dahan L, Conroy T, Ghiringhelli F, Drouillard A, El Hajbi F, Samalin E, Hiret S, Delaine-Clisant S, Mariette C, Penel N, Piessen G, Le Deley MC.

Eur J Cancer. 2019 Apr;111:12-20. doi: 10.1016/j.ejca.2019.01.016. Epub 2019 Feb 22.


KEYNOTE-590: Phase III study of first-line chemotherapy with or without pembrolizumab for advanced esophageal cancer.

Kato K, Shah MA, Enzinger P, Bennouna J, Shen L, Adenis A, Sun JM, Cho BC, Özgüroğlu M, Kojima T, Kostorov V, Hierro C, Zhu Y, McLean LA, Shah S, Doi T.

Future Oncol. 2019 Apr;15(10):1057-1066. doi: 10.2217/fon-2018-0609. Epub 2019 Feb 8.


Temporal trend of the proportion of patients presenting with advanced HIV in French Guiana: stuck on the asymptote?

Nacher M, Huber F, Adriouch L, Djossou F, Adenis A, Couppié P.

BMC Res Notes. 2018 Nov 26;11(1):831. doi: 10.1186/s13104-018-3944-y.


Continuation of Bevacizumab vs Cetuximab Plus Chemotherapy After First Progression in KRAS Wild-Type Metastatic Colorectal Cancer: The UNICANCER PRODIGE18 Randomized Clinical Trial.

Bennouna J, Hiret S, Bertaut A, Bouché O, Deplanque G, Borel C, François E, Conroy T, Ghiringhelli F, des Guetz G, Seitz JF, Artru P, Hebbar M, Stanbury T, Denis MG, Adenis A, Borg C.

JAMA Oncol. 2019 Jan 1;5(1):83-90. doi: 10.1001/jamaoncol.2018.4465.


Histoplasma capsulatum antigen detection tests as an essential diagnostic tool for patients with advanced HIV disease in low and middle income countries: A systematic review of diagnostic accuracy studies.

Nacher M, Blanchet D, Bongomin F, Chakrabarti A, Couppié P, Demar M, Denning DW, Djossou F, Epelboin L, Govender N, Leitão T, Mac Donald S, Mandengue C, Marques da Silva SH, Oladele R, Panizo MM, Pasqualotto A, Ramos R, Swaminathan S, Rodriguez-Tudela JL, Vreden S, Zancopé-Oliveira R, Adenis A.

PLoS Negl Trop Dis. 2018 Oct 19;12(10):e0006802. doi: 10.1371/journal.pntd.0006802. eCollection 2018 Oct.


Spatial dynamics and epidemiology for AIDS in remote areas in French Guiana.

Mosnier E, Epelboin L, Guiraud N, Huber F, Adriouch L, Guarmit B, Brousse P, Terraz A, Boser A, Gaillet M, Djossou F, Adenis A, Nacher M.

AIDS Care. 2019 Apr;31(4):498-504. doi: 10.1080/09540121.2018.1524111. Epub 2018 Oct 4.


An extended phase Ib study of epertinib, an orally active reversible dual EGFR/HER2 tyrosine kinase inhibitor, in patients with solid tumours.

Arkenau HT, Italiano A, Mak G, Toulmonde M, Baird RD, Garcia-Corbacho J, Plummer R, Flynn M, Forster M, Wilson RH, Tosi D, Adenis A, Donaldson K, Posner J, Kawabata I, Arimura A, Deva S, Spicer J.

Eur J Cancer. 2018 Nov;103:17-23. doi: 10.1016/j.ejca.2018.07.134. Epub 2018 Sep 6.


Burden of HIV-associated histoplasmosis compared with tuberculosis in Latin America: a modelling study.

Adenis AA, Valdes A, Cropet C, McCotter OZ, Derado G, Couppie P, Chiller T, Nacher M.

Lancet Infect Dis. 2018 Oct;18(10):1150-1159. doi: 10.1016/S1473-3099(18)30354-2. Epub 2018 Aug 23.


Once weekly paclitaxel associated with a fixed dose of oral metronomic cyclophosphamide: a dose-finding phase 1 trial.

Pannier D, Adenis A, Bogart E, Dansin E, Clisant-Delaine S, Decoupigny E, Lesoin A, Amela E, Ducornet S, Meurant JP, Le Deley MC, Penel N.

BMC Cancer. 2018 Jul 31;18(1):775. doi: 10.1186/s12885-018-4678-x.


Estimation of the duration between HIV seroconversion and HIV diagnosis in different population groups in French Guiana: Strategic information to reduce the proportion of undiagnosed infections.

Nacher M, Adenis A, Huber F, Hallet E, Abboud P, Mosnier E, Bideau B, Marty C, Lucarelli A, Morel V, Lacapère F, Epelboin L, Couppié P.

PLoS One. 2018 Jun 22;13(6):e0199267. doi: 10.1371/journal.pone.0199267. eCollection 2018.


Modeling of the HIV epidemic and continuum of care in French Guiana.

Nacher M, Adriouch L, Huber F, Vantilcke V, Djossou F, Elenga N, Adenis A, Couppié P.

PLoS One. 2018 May 24;13(5):e0197990. doi: 10.1371/journal.pone.0197990. eCollection 2018.


Questions About a Clinical Trial Evaluating the Addition of Cetuximab to Definitive Chemoradiation Therapy With Paclitaxel and Cisplatin for Patients With Esophageal Cancer.

Adenis A, Lordick F.

JAMA Oncol. 2018 Jun 1;4(6):887-888. doi: 10.1001/jamaoncol.2018.0239. No abstract available.


[Initiation of first dialysis and three months quality of life of patients with end stage renal disease in the French territories of Guadeloupe and Guyane].

Deloumeaux J, Samut G, Rochemont D, Merault H, Dufresne R, Galantine V, Tirolien Y, Léonardi C, Adenis A, Peruvien J, Nacher M, Gabriel JM.

Nephrol Ther. 2018 Nov;14(6):467-473. doi: 10.1016/j.nephro.2017.12.002. Epub 2018 Feb 22. French.


Country of infection among HIV-infected patients born abroad living in French Guiana.

Nacher M, Adriouch L, Van Melle A, Parriault MC, Adenis A, Couppié P.

PLoS One. 2018 Feb 8;13(2):e0192564. doi: 10.1371/journal.pone.0192564. eCollection 2018.


The FREGAT biobank: a clinico-biological database dedicated to esophageal and gastric cancers.

Mariette C, Renaud F, Piessen G, Gele P, Copin MC, Leteurtre E, Delaeter C, Dib M, Clisant S, Harter V, Bonnetain F, Duhamel A, Christophe V, Adenis A; Fregat Working Group.

BMC Cancer. 2018 Feb 6;18(1):139. doi: 10.1186/s12885-018-3991-8.


Histoplasmosis: An oral malignancy-like clinical picture.

Chroboczek T, Dufour J, Renaux A, Aznar C, Demar M, Couppie P, Adenis A.

Med Mycol Case Rep. 2018 Jan 17;19:45-48. doi: 10.1016/j.mmcr.2017.11.001. eCollection 2018 Mar.


Predictors of abnormal cytology among HPV-infected women in remote territories of French Guiana.

Adenis A, Dufit V, Douine M, Ponty J, Bianco L, Najioullah F, Kilié O, Catherine D, Thomas N, Deshayes JL, Brousse P, Carles G, Grenier C, Lacoste V, Molinie V, Cesaire R, Nacher M.

BMC Womens Health. 2018 Jan 24;18(1):25. doi: 10.1186/s12905-017-0493-9.


Impact of early palliative care on overall survival of patients with metastatic upper gastrointestinal cancers treated with first-line chemotherapy: a randomised phase III trial.

Hutt E, Da Silva A, Bogart E, Le Lay-Diomande S, Pannier D, Delaine-Clisant S, Le Deley MC, Adenis A.

BMJ Open. 2018 Jan 23;8(1):e015904. doi: 10.1136/bmjopen-2017-015904. Erratum in: BMJ Open. 2019 May 30;9(5):e015904corr1.


Consolidation chemotherapy after definite concurrent chemoradiation in patients with non-operable esophageal cancer: Is it useful?

Adenis A, Castan F, Conroy T.

Radiother Oncol. 2018 Oct;129(1):180-181. doi: 10.1016/j.radonc.2017.12.018. Epub 2018 Jan 10. No abstract available.


Definitive chemoradiation for resectable carcinoma of the cervical esophagus: do we need more evidence?

Adenis A, Piessen G, Azria D.

Ann Transl Med. 2017 Dec;5(24):503. doi: 10.21037/atm.2017.10.27. No abstract available.


[FREGAT: French clinico-biological database dedicated to esogastric cancers].

Renaud F, Bibeau F, Leteurtre E, Delaeter C, Dib M, Harter V, Adenis A, Piessen G, Mariette C; FREGAT working group.

Ann Pathol. 2017 Dec;37(6):457-466. doi: 10.1016/j.annpat.2017.10.005. Epub 2017 Nov 28. French.


Aurora A Functional Single Nucleotide Polymorphism (SNP) Correlates With Clinical Outcome in Patients With Advanced Solid Tumors Treated With Alisertib, an Investigational Aurora A Kinase Inhibitor.

Niu H, Shin H, Gao F, Zhang J, Bahamon B, Danaee H, Melichar B, Schilder RJ, Coleman RL, Falchook G, Adenis A, Behbakht K, DeMichele A, Dees EC, Perez K, Matulonis U, Sawrycki P, Huebner D, Ecsedy J.

EBioMedicine. 2017 Nov;25:50-57. doi: 10.1016/j.ebiom.2017.10.015. Epub 2017 Oct 16.


Itraconazole and antiretroviral therapy: strategies for empirical dosing - Author's reply.

Le T, Adenis A, Limper A, Harrison T.

Lancet Infect Dis. 2017 Nov;17(11):1123-1124. doi: 10.1016/S1473-3099(17)30582-0. No abstract available.


Life-Threatening Irinotecan-Induced Toxicity in an Adult Patient with Alveolar Rhabdomyosarcoma: The Role of a UGT1A1 Polymorphism.

Jannin A, Hennart B, Adenis A, Chauffert B, Penel N.

Case Rep Oncol Med. 2017;2017:2683478. doi: 10.1155/2017/2683478. Epub 2017 Sep 26.


Predictors of complications of snake envenomation in Cayenne, French Guiana, 2007-2015.

Mutricy R, Egmann G, Marty C, Houcke S, Adenis A, Douine M, Nacher M, Epelboin L.

Intensive Care Med. 2018 Jan;44(1):115-117. doi: 10.1007/s00134-017-4929-3. Epub 2017 Sep 6. No abstract available.


Dovitinib in patients with gastrointestinal stromal tumour refractory and/or intolerant to imatinib.

Joensuu H, Blay JY, Comandone A, Martin-Broto J, Fumagalli E, Grignani G, Del Muro XG, Adenis A, Valverde C, Pousa AL, Bouché O, Italiano A, Bauer S, Barone C, Weiss C, Crippa S, Camozzi M, Castellana R, Le Cesne A.

Br J Cancer. 2017 Oct 24;117(9):1278-1285. doi: 10.1038/bjc.2017.290. Epub 2017 Aug 29.


Radiological imaging markers predicting clinical outcome in patients with metastatic colorectal carcinoma treated with regorafenib: post hoc analysis of the CORRECT phase III trial (RadioCORRECT study).

Ricotta R, Verrioli A, Ghezzi S, Porcu L, Grothey A, Falcone A, Van Cutsem E, Argilés G, Adenis A, Ychou M, Barone C, Bouché O, Peeters M, Humblet Y, Mineur L, Sobrero AF, Hubbard JM, Cremolini C, Prenen H, Tabernero J, Jarraya H, Mazard T, Deguelte-Lardiere S, Papadimitriou K, Van den Eynde M, Pastorino A, Redaelli D, Bencardino K, Funaioli C, Amatu A, Carlo-Stella G, Torri V, Sartore-Bianchi A, Vanzulli A, Siena S.

ESMO Open. 2017 Feb 13;1(6):e000111. doi: 10.1136/esmoopen-2016-000111. eCollection 2016.


Health-related quality of life results from the PRODIGE 5/ACCORD 17 randomised trial of FOLFOX versus fluorouracil-cisplatin regimen in oesophageal cancer.

Bascoul-Mollevi C, Gourgou S, Galais MP, Raoul JL, Bouché O, Douillard JY, Adenis A, Etienne PL, Juzyna B, Bedenne L, Conroy T.

Eur J Cancer. 2017 Oct;84:239-249. doi: 10.1016/j.ejca.2017.07.038. Epub 2017 Aug 19.


Fungal infections in HIV/AIDS.

Limper AH, Adenis A, Le T, Harrison TS.

Lancet Infect Dis. 2017 Nov;17(11):e334-e343. doi: 10.1016/S1473-3099(17)30303-1. Epub 2017 Jul 31. Review.


Neoadjuvant chemoradiotherapy for oesophageal cancer: Still looking for a challenger to the CROSS regimen.

Adenis A, Mariette C.

Eur J Cancer. 2017 Sep;83:331-332. doi: 10.1016/j.ejca.2017.06.039. Epub 2017 Jul 20. No abstract available.


Illegal gold miners in French Guiana: a neglected population with poor health.

Douine M, Mosnier E, Le Hingrat Q, Charpentier C, Corlin F, Hureau L, Adenis A, Lazrek Y, Niemetsky F, Aucouturier AL, Demar M, Musset L, Nacher M.

BMC Public Health. 2017 Jul 17;18(1):23. doi: 10.1186/s12889-017-4557-4. Erratum in: BMC Public Health. 2017 Sep 22;17 (1):736.


Paid HIV rapid testing in general medicine private practice in French Guiana: a pilot project.

Sangare I, Jolivet A, Adenis A, Adriouch L, Levy-Loeb M, Dimanche S, Vantilcke V, Marty C, Couppié P, Nacher M.

Public Health. 2017 Oct;151:23-26. doi: 10.1016/j.puhe.2017.06.002. Epub 2017 Jul 10. No abstract available.


High mortality among male HIV-infected patients after prison release: ART is not enough after incarceration with HIV.

Huber F, Merceron A, Madec Y, Gadio G, About V, Pastre A, Coupez I, Adenis A, Adriouch L, Nacher M.

PLoS One. 2017 Apr 28;12(4):e0175740. doi: 10.1371/journal.pone.0175740. eCollection 2017.


A multicenter phase II study of personalized FOLFIRI-cetuximab for safe dose intensification.

Boisdron-Celle M, Metges JP, Capitain O, Adenis A, Raoul JL, Lecomte T, Lam YH, Faroux R, Masliah C, Poirier AL, Berger V, Morel A, Gamelin E.

Semin Oncol. 2017 Feb;44(1):24-33. doi: 10.1053/j.seminoncol.2017.02.007. Epub 2017 Feb 9.


The singular epidemiology of HPV infection among French Guianese women with normal cytology.

Adenis A, Dufit V, Douine M, Najioullah F, Molinie V, Catherine D, Kilié O, Thomas N, Deshayes JL, Brousse P, Amor HB, Pignoux R, Carles G, Grenier C, Lacoste V, Cesaire R, Nacher M.

BMC Public Health. 2017 Mar 24;17(1):279. doi: 10.1186/s12889-017-4181-3.


Cutaneous leishmaniasis in French Guiana: revising epidemiology with PCR-RFLP.

Simon S, Nacher M, Carme B, Basurko C, Roger A, Adenis A, Ginouves M, Demar M, Couppie P.

Trop Med Health. 2017 Feb 28;45:5. doi: 10.1186/s41182-017-0045-x. eCollection 2017.


High prevalence of HPV infection in the remote villages of French Guiana: an epidemiological study.

Adenis A, Dufit V, Douine M, Corlin F, Ayhan G, Najioullah F, Molinie V, Brousse P, Carles G, Lacoste V, Cesaire R, Nacher M.

Epidemiol Infect. 2017 Apr;145(6):1276-1284. doi: 10.1017/S0950268816003319. Epub 2017 Jan 16.


Efficacy and safety of nab-paclitaxel in patients with previously treated metastatic colorectal cancer: a phase II COLO-001 trial.

Ducreux M, Bennouna J, Adenis A, Conroy T, Lièvre A, Portales F, Jeanes J, Li L, Romano A.

Cancer Chemother Pharmacol. 2017 Jan;79(1):9-16. doi: 10.1007/s00280-016-3193-5. Epub 2016 Nov 19.


Signet Ring Cells and Efficacy of First-line Chemotherapy in Advanced Gastric or Oesogastric Junction Adenocarcinoma.

Lemoine N, Adenis A, Bouche O, Duhamel A, Heurgue A, Leteurtre E, Amela E, Salleron J, Hebbar M.

Anticancer Res. 2016 Oct;36(10):5543-5549.


Esophageal Adenocarcinoma: Impact of a Large Hiatal Hernia on Outcomes After Surgery.

Gandon A, Gronnier C, Renaud F, Borde P, Vanderbeken M, Hec F, Piessen G, Adenis A, Mirabel X, Mariette C.

Ann Surg. 2016 Nov;264(5):862-870.


Lack of Relationship Between Clinical Features and KRAS Mutations in Patients with Metastatic Colorectal Cancer.

Ploquin A, Zerimech F, Escande F, Adenis A, Giraud C, Gasnault L, Bourgeois V, Desauw C, Hebbar M.

Anticancer Res. 2016 Aug;36(8):4233-6.


Erratum to: Survival, safety, and prognostic factors for outcome with Regorafenib in patients with metastatic colorectal cancer refractory to standard therapies: results from a multicenter study (REBECCA) nested within a compassionate use program.

Adenis A, de la Fouchardiere C, Paule B, Burtin P, Tougeron D, Wallet J, Dourthe LM, Etienne PL, Mineur L, Clisant S, Phelip JM, Kramar A, Andre T.

BMC Cancer. 2016 Jul 25;16(1):518. No abstract available.

Supplemental Content

Loading ...
Support Center